Cystic fibrosis is among the most common, known and studied genetic diseases. It affects over 100,000 people worldwide and ...

The gene editing treatment targets the relatively common 1717-1G>A splicing mutation, which does not respond to many current CF therapies.

Researchers at the University of Trento have developed a CRISPR-based adenine base editing therapy that repaired the ...

Please provide your email address to receive an email when new articles are posted on . Few patients with cystic fibrosis have a copy of the 3849+10kb C-to-T splicing mutation. Research is planned to ...

Cystic fibrosis (CF) is a rare autosomal recessive disorder that affects numerous systems of the body. It is a complicated disease that differs from person to person. An autosomal recessive disorder ...

This photo provided by Emilys Entourage in April 2025 shows Emily Kramer-Golinkoff, who has cystic fibrosis caused by a rare genetic mutation, during a trip to Maine. (Emilys Entourage via AP) ...

Cystic fibrosis (CF) is a common genetic disorders that has been well studied. Researchers have identified CF-causing mutations in a gene called CFTR, which encodes for an ion channel. The genetic ...

Diagnosis of CF can be made independent of the identification of mutations in the CFTR gene. Justification of mutation diagnosis is based on the fact that it enables rapid, early, definitive diagnosis ...

BETHESDA, Md.--(BUSINESS WIRE)--Today, the Cystic Fibrosis Foundation announced an additional investment of up to $24 million in Prime Medicine to continue the development of a gene editing therapy ...

Add Yahoo as a preferred source to see more of our stories on Google. The genetic disorder cystic fibrosis is unique because it can cause both breathing and digestive problems. Some 40,000 people in ...